Ravi Kiron

Ravi Kiron is a highly experienced professional in the pharmaceutical and biotechnology industries, currently serving as Managing Director at Biopharma Strategy Advisors.1 Here's a detailed profile of Ravi Kiron based on the information available:

Professional Background

Ravi Kiron has an extensive career spanning various sectors of the healthcare and life sciences industry. His expertise includes:

• Pharma and biotech strategy
• Venture capital and investing
• Corporate development and M&A
• Business development consulting
• Academia collaborations

Career Highlights

• Head of Strategic Innovation R&D at EMD Serono, Inc. (June 2017 - July 2023)1
• Co-founder of four startup companies
• Experience with major pharmaceutical companies including Pfizer, J&J, and Merck KGaA
• Involvement in corporate venture capital

Education

• Ph.D. in Biochemistry from the Indian Institute of Science (IISc) (1982 - 1986)1
• MBA in Entrepreneurship (specific institution not mentioned)

Areas of Expertise

Ravi Kiron has worked across multiple therapeutic areas, including:

• Cardiovascular, Metabolic Diseases (CVMD)
• Central Nervous System (CNS)
• Oncology
• Inflammation
• Fertility and FemTech
• Aging
• Artificial Intelligence in healthcare
• Microbiome research

Skills and Strengths

• Forging partnerships and deals across technologies and therapeutic areas1
• Developing strategic initiatives through focused leadership
• Leveraging game-changing technologies for healthcare applications
• Extensive global network in pharma, biotech, and academia (over 11,000 LinkedIn connections)1
• Experience in fundraising, strategy development, and technology assessment

Languages

Ravi Kiron is proficient in multiple languages:

• English (native or bilingual)
• Hindi (professional working)
• Kannada (native or bilingual)
• Telugu (native or bilingual)
• Konkani (professional working)
• Marathi (elementary)1

In his current role as Managing Director at Biopharma Strategy Advisors, Ravi Kiron likely leverages his vast experience to provide strategic guidance and consulting services to pharmaceutical and biotechnology companies.